Linked page lives on the broker site, not on OpenAcquisitions.
Key points
•Develops proprietary antibodies and assays; serves pharmaceutical, government, and academic clients with 25+ years of expertise.
•Generates recurring manufacturing contracts with high customer switching costs and few direct competitors.
•Business model relies on proprietary intellectual property in antibody technology.
Business description
Life sciences reagent and immunoassay business with proprietary monoclonal antibody IP, a GLP-compliant facility, and a tenured six-person team that runs operations independently of the owner.
